Results 31 to 40 of about 3,582 (175)

Sclerotherapy for Oral Pyogenic Granuloma – A case report

open access: yesJournal of College of Medical Sciences-Nepal, 2017
First described by Hullihen in 1844, Pyogenic granuloma (PG) is a benign, exophytic vascular tumor. It is not infective, purulent or granulomatous but a reactive inflammatory mass of blood vessels with few fibroblasts within the mucosa or skin.
Pragya Regmee   +5 more
doaj   +1 more source

Use of Sodium Tetradecyl Sulphate for Treatment of Oral Lesions

open access: yesJournal of College of Medical Sciences-Nepal, 2019
Background: Sclerotherapy is defined as the “targeted elimination of small vessels, varicose veins and vascular anomalies by the injection of a sclerosant. This study aimed to analyze the effect of a sclerosing agent 3% Sodium tetradecyl sulfate (STS) on
Peeyush Shivhare   +2 more
doaj   +1 more source

Sclerotherapy for hemangioma of the labial mucosa

open access: yesIndian Journal of Paediatric Dermatology, 2016
Hemangiomas are hamartomatous proliferations of vascular origin. The prevalence of these lesions is about 7% of all the benign tumors of the body. The clinical appearance of hemangiomas varies depending on the location of the vascular proliferation ...
Srikanth H Srivathsa
doaj   +1 more source

Cavernous hemangioma of the glans penis

open access: yesUrology Annals, 2015
Cavernous hemangioma of the glans penis is a very rare lesion, and only a few cases are reported in the literature. Urologists are in a dilemma to treat such lesion with cosmetic and to obtain good functional outcome.
Soumya Mondal   +2 more
doaj   +1 more source

Efficacy and safety of sclerosants in the treatment of venous malformations: A network meta-analysis of randomized controlled trials

open access: yesChinese Journal of Plastic and Reconstructive Surgery, 2022
Background: Venous malformations (VMs) are the most common low-flow vascular malformations. Although various sclerosants are effective, their relative effects have not yet been well established.
Wei Lu   +3 more
doaj   +1 more source

The Addition of Lipid-Based Contrast Medium does not Inactivate the Detergent Sclerosant Sodium Tetradecyl Sulfate in-vitro.

open access: yes, 2021
PURPOSE To investigate if the detergent sclerosant sodium tetradecyl sulfate (STS) is deactivated by the lipid-based contrast agent ethiodised oil.
Brown, Judy   +4 more
core   +1 more source

Preoperative Sclerotherapy Using Sodium Tetradecyl Sulphate (Fibro-Vein™) Can Assist in the Management of Vertebral Hemangiomas

open access: yesGlobal Spine Journal, 2012
Vertebral hemangiomas are benign lesions accounting for 2 to 3% of all spinal tumors. They are usually asymptomatic and found incidentally on imaging. Uncommonly, vertebral hemangiomas with significant epidural extension can result in radiculopathy or ...
Omprakash Damodaran B.Med.   +4 more
doaj   +1 more source

A Rare Case Presentation of Synovial Haemangioma of the Knee [PDF]

open access: yesJournal of Clinical and Diagnostic Research
Synovial haemangioma is a benign vascular neoplasm that commonly affects the knee joint. It is often underdiagnosed as a cause of chronic knee pain, leading to delays in the management of this rare tumour.
Arun Karthik Ravichandran   +4 more
doaj   +1 more source

Sclerotherapy – A novel modality in the management of oral pyogenic granuloma

open access: yesJournal of Indian Society of Periodontology, 2021
Pyogenic granuloma is a commonly occurring inflammatory hyperplasia involving the oral cavity. Surgical resection of the lesion is the mainstay treatment of pyogenic granuloma.
Abhishek Govind Soni
doaj   +1 more source

Haemangiomas and venous malformations of the head and neck: A retrospective analysis of endovascular management in 358 patients

open access: yesIndian Journal of Plastic Surgery, 2013
Background: Haemangioma (HM) and venous malformations of the head and neck are formidable lesions as they cause cosmetic deformity and psychological problems.
Kumbhar Sachin   +4 more
doaj   +1 more source

Home - About - Disclaimer - Privacy